Literature DB >> 25816413

TENS effects on salivary stress markers: A pilot study.

E Ortu1, D Pietropaoli2, G Mazzei2, R Cattaneo2, M Giannoni2, A Monaco2.   

Abstract

Transcutaneous electrical nerve stimulation (TENS) is extensively used as pain relief through endorphins release. Moreover, recent findings showed a role in the activation of the autonomic nervous system (ANS); it was evidenced by modification in the heart rate variability and ANS-related marker. The objective of this pilot study is to evaluate salivary alpha amylase (sAA) as a marker of stress in two groups of healthy subjects, one receiving ultra-low frequency transcutaneous electrical nerve stimulation (ULF-TENS) and one without stimulation. Sixty healthy people were enrolled. The test group consisted of 30 participants (15 men, 15 women). The control group consisted of 30 participants (15 men, 15 women). Statistical analysis showed that sAA levels were statistically different between men and women independently from TENS; we hypothesize that treatment could influence sAA levels because it is thought to activate μ opioid receptors. The results of this study seem to indicate that the analysis of sAA, through a non-invasive saliva sample, could be an efficient aid for understanding the functions of the autonomic nervous system.
© The Author(s) 2015.

Entities:  

Keywords:  TENS; saliva; salivary alpha amylase; stress

Mesh:

Substances:

Year:  2015        PMID: 25816413     DOI: 10.1177/0394632015572072

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  2 in total

1.  A Device Improves Signs and Symptoms of TMD.

Authors:  Davide Pietropaoli; Barry C Cooper; Eleonora Ortu; Annalisa Monaco
Journal:  Pain Res Manag       Date:  2019-05-06       Impact factor: 3.037

2.  Orthodontic management by functional activator treatment: a case report.

Authors:  Giuseppe Aprile; Eleonora Ortu; Ruggero Cattaneo; Davide Pietropaoli; Mario Giannoni; Annalisa Monaco
Journal:  J Med Case Rep       Date:  2017-12-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.